AI and Personalized Medicine: The Next Chapter for Lifestyle Drug R&D
The Renaissance of Well-Being: A Visionary Outlook for the Global Lifestyle Drugs Market (2024–2030) Executive Summary: Redefining the Pharmaceutical Mandate The global pharmaceutical landscape is currently witnessing its most significant paradigm shift since the antibiotic revolution. The Global Lifestyle Drugs Market, valued at USD 108.71 Billion in 2023, is no longer a...
0 Commentaires 0 Parts 173 Vue